Marathon Trading Investment Management LLC Esperion Therapeutics, Inc. Transaction History

Marathon Trading Investment Management LLC

  • $201 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$1.84 - $3.24 $256,551 - $451,753
-139,430 Reduced 81.78%
31,070 $68,000
Q1 2024

May 10, 2024
BUY
$2.02 - $3.02 $301,990 - $451,490
149,500 Added 711.9%
170,500 $456,000
Q4 2023

Feb 13, 2024
BUY
$0.73 - $3.08 $15,330 - $64,680
21,000 New
21,000 $62,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $168M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email